Elevated levels of serum CA-125 and NSE in a patient with desmoplastic tumor.
Mäkipernaa
A
A
Lähde
P L
PL
D000008:Abdominal Neoplasms / Q000097:blood / Q000175:diagnosis*; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D016026:Bone Marrow Transplantation; D018394:CA-125 Antigen / Q000097:blood*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D018220:Fibroma, Desmoplastic / Q000097:blood* / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D008297:Male; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D012008:Recurrence; D013852:Thiotepa / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D010751:Phosphopyruvate Hydratase; D002945:Cisplatin